An evidence synthesis approach to estimating Hepatitis C Prevalence in England and Wales

In England and Wales, routine monitoring has been consistently showing an increase in mortality and morbidity due to infection with the Hepatitis C Virus (HCV). However, the magnitude of the underlying epidemic is still the subject of debate. In this paper we present estimates of the number of individuals aged 15—59 chronically infected with HCV in 2003, derived from a Bayesian synthesis of information available from multiple sources on the size of the groups at risk for HCV and the risk specific anti-HCV prevalence. Results show that the number of chronic infections is of the order of 142,000 (95% CrI: 90,000, 231,000), with the majority (85%, 95% CrI: 74%, 93%) in injecting drug users and about 80% (95% CrI: 74%, 84%) in the age group 15—44.

[1]  D. De Angelis,et al.  Estimating the prevalence of ex-injecting drug use in the population , 2009, Statistical methods in medical research.

[2]  A E Ades,et al.  Estimating hepatitis C prevalence in England and Wales by synthesizing evidence from multiple data sources. Assessing data conflict and model fit. , 2008, Biostatistics.

[3]  Catherine H Mercer,et al.  Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data , 2008 .

[4]  V. Hope,et al.  Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004 , 2007, Journal of viral hepatitis.

[5]  Peter B. Jones,et al.  Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. , 2007, Addiction.

[6]  M. Ramsay,et al.  Hepatitis C virus: laboratory surveillance in England and Wales, 1992–2004 , 2006, Epidemiology and Infection.

[7]  W. Irving,et al.  Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection , 2006, Epidemiology and Infection.

[8]  J. Kaldor,et al.  Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies , 2006, Journal of viral hepatitis.

[9]  K. Tilling,et al.  Capturing crack cocaine use: estimating the prevalence of crack cocaine use in London using capture-recapture with covariates. , 2005, Addiction.

[10]  S. Bird,et al.  Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland , 2005, Hepatology.

[11]  Nicky J Welton,et al.  A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence , 2005 .

[12]  M. Bellis,et al.  Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators , 2004, Journal of Epidemiology and Community Health.

[13]  J. Kaldor,et al.  Hepatitis C prevalence--a nationwide serosurvey. , 2004, Communicable diseases intelligence quarterly report.

[14]  J. Kaldor,et al.  Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. , 2003, International journal of epidemiology.

[15]  J. Parry,et al.  Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots , 2003, Journal of medical virology.

[16]  J. Parry,et al.  A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection , 2003, Sexually transmitted infections.

[17]  H. Meltzer,et al.  Psychiatric morbidity among adults living in private households, 2000 , 2003, International review of psychiatry.

[18]  Ruth King,et al.  Bayesian model discrimination for multiple strata capture‐recapture data , 2002 .

[19]  L. Seeff.  Natural history of chronic hepatitis C , 2002 .

[20]  N. Andrews,et al.  The prevalence of hepatitis C in England and Wales. , 2002, The Journal of infection.

[21]  L. Seeff,et al.  Natural history of chronic hepatitis C , 2002, Hepatology.

[22]  J. Parry,et al.  The prevalence and genetic diversity of hepatitis C infection in antenatal clinic attenders in two regions of England , 2000, Epidemiology and Infection.

[23]  A. Ades,et al.  HCV prevalence in pregnant women in the UK , 2000, Epidemiology and Infection.

[24]  Cormack Rm,et al.  Problems with using capture-recapture in epidemiology: an example of a measles epidemic. , 1999 .

[25]  Inda,et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.

[26]  R. Cormack,et al.  Problems with using capture-recapture in epidemiology: an example of a measles epidemic. , 1999, Journal of clinical epidemiology.

[27]  Andrew Gelman,et al.  General methods for monitoring convergence of iterative simulations , 1998 .

[28]  J. Emparanza,et al.  [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.

[29]  J. York,et al.  Bayesian methods for estimation of the size of a closed population , 1997 .

[30]  R R Regal,et al.  Capture-recapture methods in epidemiology: methods and limitations. , 1995, Epidemiologic reviews.

[31]  Martin Jones.  Sexual Attitudes and Lifestyles , 1994 .